Your Article Summary
Boston Scientific Announces Schedule for European Society of Cardiology Congress
Boston Scientific, 08/28/09
Boston Scientific Corporation announced the schedule of the Company's major events and news announcements for the European Society of Cardiology Congress, which runs from August to September 2 in Barcelona. Highlights include final results from the MADIT–CRT trial and two–year results from the SYNTAX trial.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Roche, Genentech and Biogen Idec announce positive results from first phase III trial of ocrelizumab in rheumatoid arthritis
Roche, 12/14/09
Rivastigmine Transdermal Patch Skin Tolerability: Results of a 1-Year Clinical Trial in Patients with Mild-to-Moderate Alzheimer's Disease
Clinical Drug Investigation, 12/14/09
Article Search
Sponsor


See Latest Articles


